Autopsy report · NCT03496649

Pubalgia and Adductor Tendinopathies Refractory to Medical Treatment

“target number of patient not reached and lost of financial supplies”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 9 months before it started.
• Ran for about 1 year 8 months before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University Hospital, Bordeaux

Sponsor type

University, hospital or other

Conditions

Groin Injury; Tendinopathy

Interventions

Dysport 500 Unit Powder for Injection

Participants

4

Sites

1

Countries

France

Trials that died the same way

• AIDI - Research & Development of a Multisensor-Based Machine Learning Technology for Real-Time Automated Detection of COVID-19 Decompensation
  “No eligible patients could be found and funding was lost” (62% match in meaning)
• Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
  “Due to poor patient recruitment and insufficient financing.” (58% match in meaning)
• Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis
  “Lost too many patients to follow up, unable to enroll enough patients” (58% match in meaning)
• Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19
  “Lack of funding of the non-commercial sponsor to extend recruitment and reach the target number of patients specified in the protocol.” (57% match in meaning)
• Effects (Long Term Analysis) of an Hyperproteinic Nutrition on Neonates With Intra-uterine Growth Delay : a Prospective, Multicentric , Randomized, Double Blind Study ("Proneonat")
  “difficulties of recruitment, high number of patients lost to follow-up” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.